List of Bioinformatics Companies in Indiana - 3
Search through the full list with powerful filtering options
Want this in Excel? Get Quote NowCompany | About |
---|---|
AniDyn West Lafayette, Indiana, United States | BioDynamic Imaging delivers better drug assessment in three-dimensional (3D) living tissue samples, revealing a comprehensive phenotypic response that is more physiologically meaningful than from conventional 2D or monolayer screens. Our technique is label-free and probes up to 1 mm deep in living tissue to study drug response in heterogeneous tissue environments. BioDynamic Imaging converts all forms of functional cellular motions into contrast maps of cellular mechanisms of action. |
Modicus Prime La Porte, Indiana 46350, US | Modicus Prime's Self-Service software places cutting-edge AI where it belongs: in the hands of biotechnology experts. Our computer vision solution, mpVision, provides intelligent image analysis to monitor biologics at any scale. mpVision has been tested by scientists in a Top 10 Pharma company supporting our mission to eliminate contamination from the pharmaceutical industry. These contaminations cost 100’s of millions of dollars per incident as illustrated by the recent Covid vaccine 60 M incident experienced by J&J/AstraZeneca/Emergent. Such unmet needs of the Life Sciences industry, including real-time product quality assurance, full agency compliance, faster go-to-market, and reduced operating costs, are being met with Modicus Prime’s Self-Service AI solution. |
Syndeio Biosciences Indianapolis, Indiana, United States | Syndeio Biosciences (from the Ancient Greek word “to connect”) is a clinical-stage biotechnology company developing therapies to restore and enhance synaptic health in CNS disorders. The company’s proprietary Boost™ Synapse Pharmacology Platform combines electrophysiology, behavior, and human neuronal network assays to predict clinical outcomes with unprecedented accuracy. Syndeio’s clinical pipeline includes lead asset, zelquistinel, currently in Phase 2 development for major depressive disorder and will soon be entering an industry-first biomarker study in Alzheimer’s disease, and apimostinel, currently in an investigator-led phase 2 study for acute depression. The company is headquartered in Indianapolis, IN with research laboratories in Menlo Park, CA & Evanston, IL focused on advancing the Boost™ Synapse Pharmacology Platform. |